Stay updated on HOPE-B: AMT-061 Clinical Trial
Sign up to get notified when there's something new on the HOPE-B: AMT-061 Clinical Trial page.

Latest updates to the HOPE-B: AMT-061 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUpdated the trial location entry from Malmo to Malmö in Sweden (SE-205 02) to reflect the correct city spelling in the locations list.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page revision identifier was incremented from v3.5.2 to v3.5.3, reflecting an underlying site/version update rather than a change to the study information.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page revision tag has been updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded new data points and definitions for outcomes and safety, including Month 60 AFP levels, inflammatory markers, anti-AAV5 antibodies, vector DNA shedding, adverse events, and multiple FIX activity and bleeding endpoints with specified timepoints. Deleted older endpoints and measurement definitions (for example ABR calculation method, lead-in FIX consumption and activity metrics, and some lead-in/18-month timepoints) to align with updated study reporting.SummaryDifference3%

- Check56 days agoChange DetectedUpdated the site revision from v3.4.3 to v3.5.0; the page content and user workflows remain unchanged.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2. The update does not modify study information, eligibility criteria, or results.SummaryDifference0.0%

Stay in the know with updates to HOPE-B: AMT-061 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HOPE-B: AMT-061 Clinical Trial page.